541299 Stock Overview Provides diagnostic and related healthcare tests and services in India. More details
Rewards Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
Dr Lalchandani Labs Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Dr Lalchandani Labs Historical stock prices Current Share Price ₹17.15 52 Week High ₹28.90 52 Week Low ₹15.68 Beta 0.0046 1 Month Change -4.72% 3 Month Change -20.23% 1 Year Change -31.12% 3 Year Change -55.22% 5 Year Change 64.90% Change since IPO -39.82%
Recent News & Updates
Chairman & MD recently bought ₹317k worth of stock Oct 30
First half 2025 earnings released: EPS: ₹0.35 (vs ₹0.20 loss in 1H 2024) Oct 17
Investor sentiment improves as stock rises 20% Oct 14
Dr Lalchandani Labs Limited to Report Q2, 2025 Results on Oct 14, 2024 Oct 09
Dr Lalchandani Labs Limited to Report First Half, 2025 Results on Oct 14, 2024 Oct 08
Dr Lalchandani Labs Limited, Annual General Meeting, Sep 30, 2024 Sep 12 See more updates
Chairman & MD recently bought ₹317k worth of stock Oct 30
First half 2025 earnings released: EPS: ₹0.35 (vs ₹0.20 loss in 1H 2024) Oct 17
Investor sentiment improves as stock rises 20% Oct 14
Dr Lalchandani Labs Limited to Report Q2, 2025 Results on Oct 14, 2024 Oct 09
Dr Lalchandani Labs Limited to Report First Half, 2025 Results on Oct 14, 2024 Oct 08
Dr Lalchandani Labs Limited, Annual General Meeting, Sep 30, 2024 Sep 12
Full year 2024 earnings released: EPS: ₹1.43 (vs ₹3.61 loss in FY 2023) Sep 08
New minor risk - Financial data availability Jun 01
Dr Lalchandani Labs Limited to Report Second Half, 2024 Results on May 30, 2024 May 20
Dr Lalchandani Labs Limited Approves Appointment of Namita Anand as Company Secretary and Compliance Officer May 03
Dr Lalchandani Labs Limited Announces the Resignation of Archana R Jha as Company Secretary and Compliance Officer Feb 03
Less than half of directors are independent Dec 08
Dr Lalchandani Labs Limited Announces Resignation of Monika Joshi as Company Secretary and Compliance Officer Nov 29
Dr Lalchandani Labs Limited Announces Resignation of Monika Joshi as Company Secretary and Compliance Officer Nov 28
First half 2024 earnings released: ₹0.20 loss per share (vs ₹2.24 loss in 1H 2023) Nov 20
New major risk - Financial position Nov 17
Less than half of directors are independent Nov 01
Less than half of directors are independent Sep 25
Dr Lalchandani Labs Limited Announces Resignation of Archana Jha from the Office of Company Secretary Sep 24
Dr Lalchandani Labs Limited, Annual General Meeting, Sep 30, 2023 Sep 09
Dr Lalchandani Labs Limited Appoints Monika Joshi as Company Secretary and Compliance Officer, Effective August 27, 2023 Aug 26
Less than half of directors are independent Aug 21
Less than half of directors are independent Jul 14
New major risk - Revenue and earnings growth Jun 21
Full year 2023 earnings released: ₹3.61 loss per share (vs ₹2.15 profit in FY 2022) Jun 20
Less than half of directors are independent May 25
Dr Lalchandani Labs Limited to Report Fiscal Year 2023 Results on May 30, 2023 May 25
Less than half of directors are independent May 04
Less than half of directors are independent Mar 15
Dr Lalchandani Labs Limited Announces Management Changes Feb 16
Dr Lalchandani Labs Limited Appoints Archana Jha as Company Secretary & Compliance Officer Feb 06
First half 2023 earnings released Nov 20
Less than half of directors are independent Nov 16
Dr Lalchandani Labs Limited to Report First Half, 2023 Results on Nov 14, 2022 Nov 12
Investor sentiment improved over the past week Nov 09
Investor sentiment improved over the past week Oct 19
Full year 2022 earnings released: EPS: ₹2.15 (vs ₹2.33 in FY 2021) Sep 14
Dr Lalchandani Labs Limited, Annual General Meeting, Sep 30, 2022 Sep 09
Less than half of directors are independent Aug 30
Dr Lalchandani Labs Limited Announces Resignation of CS Swati Poddar as Company Secretary and Compliance Officer Aug 10
Dr Lalchandani Labs Limited Resumes in Full Capacity At the Lab in Punjabi Bagh May 31
Investor sentiment deteriorated over the past week May 31
Dr Lalchandani Labs Limited to Report Fiscal Year 2022 Results on May 30, 2022 May 24
Investor sentiment deteriorated over the past week May 10
Less than half of directors are independent Apr 28
Investor sentiment deteriorated over the past week Apr 04
Investor sentiment deteriorated over the past week Dec 17
Investor sentiment improved over the past week Nov 24
Investor sentiment deteriorated over the past week Aug 23
Full year 2021 earnings released: EPS ₹2.33 (vs ₹1.09 in FY 2020) Jul 14
Investor sentiment improved over the past week Jul 11
Investor sentiment deteriorated over the past week Jun 25
Investor sentiment improved over the past week May 18
Investor sentiment improved over the past week Apr 15
Investor sentiment improved over the past week Mar 31
Investor sentiment deteriorated over the past week Feb 24
New 90-day low: ₹13.00 Feb 15
Dr Lalchandani Labs Limited to Report First Half, 2021 Results on Nov 13, 2020 Nov 07
Market pulls back on stock over the past week Oct 15
New 90-day high: ₹12.10 Oct 06
Full year earnings released - EPS ₹1.09 Sep 11
Dr Lalchandani Labs Limited to Report Fiscal Year 2020 Results on Jun 30, 2020 Jun 28 Shareholder Returns 541299 IN Healthcare IN Market 7D -4.2% 0.4% -0.9% 1Y -31.1% 43.5% 22.5%
See full shareholder returns
Return vs Market: 541299 underperformed the Indian Market which returned 23.9% over the past year.
Price Volatility Is 541299's price volatile compared to industry and market? 541299 volatility 541299 Average Weekly Movement 15.1% Healthcare Industry Average Movement 5.8% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.1% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 541299's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 541299's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company Dr Lalchandani Labs Limited provides diagnostic and related healthcare tests and services in India. The company offers doctor consultation, pathology, radiology, hospital lab management, corporate health checkup, and blood bank services, as well as X-ray, TMT, ultrasound, 2D-echo, medical fitness examinations, etc. It also offers its products online. The company serves individual patients, hospitals and other healthcare providers, and corporate customers.
Show more Dr Lalchandani Labs Limited Fundamentals Summary How do Dr Lalchandani Labs's earnings and revenue compare to its market cap? 541299 fundamental statistics Market cap ₹74.31m Earnings (TTM ) ₹8.58m Revenue (TTM ) ₹42.09m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 541299 income statement (TTM ) Revenue ₹42.09m Cost of Revenue ₹20.68m Gross Profit ₹21.41m Other Expenses ₹12.83m Earnings ₹8.58m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 1.98 Gross Margin 50.86% Net Profit Margin 20.37% Debt/Equity Ratio 37.5%
How did 541299 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/17 05:28 End of Day Share Price 2024/12/17 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Dr Lalchandani Labs Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
